Healthcare Global Enterprises Ltd Share Price (HCG)
₹363.6▲0.25%
Healthcare Global Enterprises Ltd share Performance
- ₹360.55₹367.9₹363.6
0.84%
Low
Day's Volatility:2.02%
High
1.18%
- ₹258₹401₹363.6
29.04%
Low
52 Weeks Volatility:39.33%
High
10.29%
| Returns % | |
| 1 Month Return | 4.65 % |
| 3 Month Return | 2.89 % |
| 1 Year Return | 39.13 % |
| Market Stats | |
| Previous Close | ₹362.70 |
| Open | ₹363.95 |
| Volume | 1.09L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹5,052.04Cr |
Analyst Rating for Healthcare Global Enterprises Ltd stock
based on 10 analysts
Based on 10 analysts offering long term price targets for Healthcare Global Enterprises Ltd. An average target of ₹414.1
Source: S&P Global Market Intelligence
Company Information
Established in 1998, HCG expanded its operations in 2016 with a successful Initial Public Offering (IPO) and launched advanced cancer centres in Baroda and Visakhapatnam. Later, in 2017, it acquired a majority stake in Cancer Care Kenya, and launched its first cancer centre in Kanpur with 90 dedicated beds. It is also setting up hospitals with high end linear accelerators in Kolkata and Nashik. HCG has been dedicated to delivering quality medical care across diagnosis and treatment, and its latest technologies like Robotic Surgery and Tomotherapy Treatment System are paving the way for a better tomorrow.
Share Price: ₹363.60 per share as on 24 Apr, 2024 04:01 PM
Market Capitalisation: ₹5,052.04Cr as of today
Revenue: ₹468.95Cr as on December 2023 (Q4 23)
Net Profit: ₹3.43Cr as on December 2023 (Q4 23)
Listing date: 30 Mar, 2016
Chairperson Name: BASAVALINGA AJAIKUMAR SADASHIVAIAH
| Organisation | Healthcare Global Enterprises Ltd |
| Headquarters | Bengaluru |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Healthcare Global Enterprises Ltd
HCG CEO Launches $20M Healthcare Fund - 18 Apr, 2024
Dr. BS Ajaikumar, co-founder and CEO of Healthcare Global Enterprises Ltd (HCG), has launched a healthcare-focused private equity-style fund worth $20 million called Inviga Healthcare Fund to support growth-stage healthcare companies. The fund has made its maiden investment of $2 million in Mynvax, a biotech start-up focused on developing novel recombinant vaccines for human respiratory viral diseases.
Healthcare Global Enterprises Ltd Delivers 27% CAGR Over 3 Years - 06 Apr, 2024
Healthcare Global Enterprises Ltd has delivered a solid 27% CAGR over the past three years, with revenue trending up by 21% each year. The share price gained 27% per year, and recent strong revenue growth suggests that it is still worth investigating.
Healthcare Global Enterprises Expands Bed Capacity, Haryana City Gas Invests in CNG Infrastructure - 20 Mar, 2024
Healthcare Global Enterprises is expanding its bed capacity by approximately 350 beds across various cities. ICICI Direct recommends a Buy rating on the stock with a target price of Rs 435 apiece. Meanwhile, Haryana City Gas Group has announced a significant investment of 500 crore rupees into the expansion of Piped Natural Gas and Compressed Natural Gas infrastructure in Gurugram.
Fundamentals of Healthcare Global Enterprises Ltd
Insights on Healthcare Global Enterprises Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 6.38% to 6.49% in Mar 2024 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 6.36% to 6.74% in Mar 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 238.4% return, outperforming this stock by 141.3%
- NO EFFECT
Against Peers
In the last 1 year, Global Health Ltd has given 185.9% return, outperforming this stock by 146.7%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 13.57 Cr → 5.7 Cr (in ₹), with an average decrease of 58.0% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 13.89% to 13.46% in Mar 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, HCG stock has moved down by -2.0%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 490.34 Cr → 475.94 Cr (in ₹), with an average decrease of 2.9% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 71.29% to 71.28% in Mar 2024 quarter
Healthcare Global Enterprises Ltd Valuation
Healthcare Global Enterprises Ltd in the last 5 years
Lowest (-514.24x)
November 27, 2018
Industry (92.49x)
April 23, 2024
Today (143.36x)
April 23, 2024
Highest (201.31x)
July 2, 2018
Mutual Fund Holdings
| Funds | Holdings |
 Tata Small Cap Fund Direct Growth | 1.81% |
 Nippon India ELSS Tax Saver Fund Direct Plan - Growth Option | 0.45% |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 1.54% |
| Tata Focused Equity Fund Direct Growth | 1.56% |
| Tata India Pharma & Healthcare Fund Direct Growth | 2.18% |
Shareholding Pattern
| Investors | Holdings % | Prev. 1 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.28% | 0.00 | |
| Foreign Institutions | 6.74% | 0.00 | |
| Mutual Funds | 6.49% | 0.00 | |
| Retail Investors | 13.46% | 0.00 | |
| Others | 2.03% | 0.00 |
Technicals of Healthcare Global Enterprises Ltd share
News & Events of Healthcare Global Enterprises Ltd
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Healthcare Global Enterprises Ltd shares.
Healthcare Global Enterprises Ltd (HCG) share price today is ₹363.6
Healthcare Global Enterprises Ltd is listed on NSE
Healthcare Global Enterprises Ltd is listed on BSE
- Today’s highest price of Healthcare Global Enterprises Ltd is ₹367.9.
- Today’s lowest price of Healthcare Global Enterprises Ltd is ₹360.55.
PE Ratio of Healthcare Global Enterprises Ltd is 143.36
PE ratio = Healthcare Global Enterprises Ltd Market price per share / Healthcare Global Enterprises Ltd Earnings per share
Today’s traded volume of Healthcare Global Enterprises Ltd(HCG) is 1.09L.
Today’s market capitalisation of Healthcare Global Enterprises Ltd(HCG) is ₹5052.04Cr.
| Healthcare Global Enterprises Ltd(HCG | Price |
|---|---|
52 Week High | ₹401 |
52 Week Low | ₹258 |
Healthcare Global Enterprises Ltd(HCG) share price is ₹363.6. It is down -9.33% from its 52 Week High price of ₹401
Healthcare Global Enterprises Ltd(HCG) share price is ₹363.6. It is up 40.93% from its 52 Week Low price of ₹258
| Healthcare Global Enterprises Ltd(HCG | Returns |
|---|---|
1 Day Returns | 0.9% |
1 Month Returns | 4.65% |
3 Month Returns | 2.89% |
1 Year Returns | 39.13% |